Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants.
about
Accurate and robust genomic prediction of celiac disease using statistical learningScreening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversyCoeliac disease and autoimmune disease-genetic overlap and screeningDeveloping and evaluating polygenic risk prediction models for stratified disease prevention.Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity.HLA-DPB1*04:01 Protects Genetically Susceptible Children from Celiac Disease Autoimmunity in the TEDDY Study.Maternal and neonatal vitamin D status, genotype and childhood celiac disease.MultiBLUP: improved SNP-based prediction for complex traits.Celiac disease and autoimmune-associated conditions.A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk.The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease.Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspectiveTNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children.Combination Testing Using a Single MSH5 Variant alongside HLA Haplotypes Improves the Sensitivity of Predicting Coeliac Disease Risk in the Polish Population.Genomic prediction of celiac disease targeting HLA-positive individuals.Salivary proline-rich proteins and gluten: Do structural similarities suggest a role in celiac disease?Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics.Interactions within the MHC contribute to the genetic architecture of celiac diseaseWhole exome sequencing of a consanguineous family identifies the possible modifying effect of a globally rare AK5 allelic variant in celiac disease development among Saudi patientsCommon polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci.Shared and unique common genetic determinants between pediatric and adult celiac disease.Diagnosing coeliac disease and the potential for serological markers.Genetics and celiac disease: the importance of screening.Transglutaminase as a therapeutic target for celiac disease.Novel diagnostic techniques for celiac disease.Different DRB1*03:01-DQB1*02:01 haplotypes confer different risk for celiac disease.Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.Predictive or not predictive: understanding the mixed messages from the patient's DNA sequence.Immunogenetics of non celiac gluten sensitivityThe burden of multiple sclerosis variants in continental Italians and Sardinians.The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk.miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation.Evaluation of Multiple Diagnostic Indicators in Comparison to the Intestinal Biopsy as the Golden Standard in Diagnosing Celiac Disease in ChildrenGut microbiota trajectory in early life may predict development of celiac disease.Search for DQ2.5 and DQ8 alleles using a lower cost technique in patients with type 1 diabetes and celiac disease in a population of southern Brazil.Galectins in Intestinal Inflammation: Galectin-1 Expression Delineates Response to Treatment in Celiac Disease Patients.Prediction of leprosy in the Chinese population based on a weighted genetic risk score
P2860
Q21563352-333121C9-C324-4C57-96F1-2639EBCC7640Q26740345-31BC35A1-2109-415D-A7BF-644DF45266D8Q28266589-5749D723-920D-4545-A026-FF003A344872Q30251440-F89B8350-A46E-4DF3-BE38-00D9EF546EA7Q30278631-8A18F436-EF10-4137-86A0-2E17AB56CE0EQ30279299-F91CECA5-C968-4A08-9590-ADE903DE2713Q33883524-BF729A25-51D0-424B-B2F0-95A07E899D5BQ34153795-C6956E20-781C-47BF-844E-EB2DB6368A9BQ34367160-FA491252-1A92-412A-A00C-94761BE7FE44Q34818495-3FD0BE43-E15F-43F4-A11F-1D1A1C3A9F8CQ35190089-5A9257EE-12D7-4258-93AF-71682236DF79Q35509448-C3419F5A-B7A4-43B3-A802-632146776ADFQ35542563-C4C414A9-731B-42B5-8D74-937521AAC85FQ35787721-F30811EC-BC93-402A-B2B5-1CAC5D93A8E7Q35913601-244C457C-5B79-47F7-8129-81099823A7E9Q36001675-0A49D75B-8E28-495B-8678-8DFDF5C3823CQ36011711-CC8D28CA-C1B4-4AA4-A013-37352C0C6378Q36304386-D0D5EC4C-6F6A-47DF-9078-A55F5B73BDE3Q36372139-9D39A49E-C318-444D-8EEA-D7A5AD963FEFQ36475056-C6FC40C0-EBD0-4A87-B8AB-7DF2AC5FA158Q37119557-00A77A83-D4F5-40B0-B4EF-EDE13FD02156Q38255279-6C022779-05F1-4B18-B619-5FE1F39E11CEQ38258052-4036D3BE-B8D3-4CBA-B46A-F875AB4A6947Q38269678-0FDB8F27-6B96-4428-9F1C-E90B9F4F8046Q38720803-76FC0900-615D-43F7-A6E1-E4EA4046EEABQ38741459-86E46DB7-E8C6-4717-B787-DB9278ECA550Q38743412-25CF75D1-F88B-4231-AFBB-19FF0394802EQ38855195-15F5330A-E181-404D-809F-40FFC287E372Q38945647-CF1452A6-E563-4007-978D-E1C803958AFFQ39493233-6C1245FA-29F7-4C0E-B401-137B4FA93263Q41260237-D4B186CE-A411-4A74-ABB9-2754D7EBAE1EQ41365044-F02E4CB5-F5BB-40D2-B225-FDB6DBB237B1Q42003313-16A555AA-04D5-4A84-AF89-1024C64DCE46Q42705610-229327B7-94F5-4B9D-8922-F80FC96269C7Q49843112-F7536737-F89D-445A-9B27-B7628FDB62E5Q50525556-C1CBB841-8B23-4F59-9A8D-1FEF5408B75CQ52353649-07515B31-F59E-4A41-B906-C603FCDD2575Q57946156-F86DA02A-AB71-4161-BA6D-F01D7A11B6D7
P2860
Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improving coeliac disease risk ...... ts additional to HLA variants.
@en
Improving coeliac disease risk ...... ts additional to HLA variants.
@nl
type
label
Improving coeliac disease risk ...... ts additional to HLA variants.
@en
Improving coeliac disease risk ...... ts additional to HLA variants.
@nl
prefLabel
Improving coeliac disease risk ...... ts additional to HLA variants.
@en
Improving coeliac disease risk ...... ts additional to HLA variants.
@nl
P2093
P2860
P50
P1433
P1476
Improving coeliac disease risk ...... ts additional to HLA variants.
@en
P2093
Agata Szperl
Andrea Steck
Anna Rosén
Concepcion Núñez
Donatella Barisani
Georges Eisenbarth
Gosia Trynka
H Marieke Boezen
Javier Gutierrez-Achury
P2860
P304
P356
10.1136/GUTJNL-2012-304110
P407
P50
P577
2013-05-23T00:00:00Z